Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases.
Ferreira
Anderson J
AJ
Departments of Physiology and Functional Genomics, University of Florida, Gainesville, Fla 32610, USA.
Santos
Robson A S
RA
Bradford
Chastity N
CN
Mecca
Adam P
AP
Sumners
Colin
C
Katovich
Michael J
MJ
Raizada
Mohan K
MK
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000818:Animals; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000517:prevention & control; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D008297:Male; D011379:Prognosis; D012084:Renin-Angiotensin System / Q000187:drug effects* / Q000502:physiology; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors